West Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . West Pharmaceutical Services
WST Stock  USD 244.35  4.49  1.80%   
Analyzing historical trends in various income statement and balance sheet accounts from West Pharmaceutical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting West Pharmaceutical's valuation are summarized below:
Gross Profit
1.1 B
Profit Margin
0.1606
Market Capitalization
18.1 B
Enterprise Value Revenue
5.7335
Revenue
3.1 B
There are currently one hundred twenty fundamental gauges for West Pharmaceutical that can be evaluated and compared over time across peers. All traders should confirm West Pharmaceutical's prevalent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 236.5 M in 2026. Enterprise Value is likely to drop to about 252.4 M in 2026

West Pharmaceutical Total Revenue

3.23 Billion

Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West Pharmaceutical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 66.2 M, Total Revenue of 3.2 B or Gross Profit of 1.2 B, as well as many indicators such as Price To Sales Ratio of 6.8, Dividend Yield of 0.0029 or PTB Ratio of 6.58. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
  
Build AI portfolio with West Stock
Check out the analysis of West Pharmaceutical Correlation against competitors.

West Pharmaceutical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.5 B4.3 B2.4 B
Slightly volatile
Short and Long Term Debt Total238.6 M416.7 M299.4 M
Pretty Stable
Other Current Liabilities397.4 M378.5 M154.4 M
Slightly volatile
Total Current Liabilities687.6 M654.9 M391.3 M
Slightly volatile
Total Stockholder Equity3.3 B3.2 B1.7 B
Slightly volatile
Property Plant And Equipment Net1.9 B1.8 B1 B
Slightly volatile
Retained Earnings4.6 B4.4 B1.9 B
Slightly volatile
Cash830.9 M791.3 M439.4 M
Slightly volatile
Non Current Assets Total2.4 B2.3 B1.4 B
Slightly volatile
Non Currrent Assets Other2.1 B2 B264.7 M
Slightly volatile
Cash And Short Term Investments830.9 M791.3 M440.6 M
Slightly volatile
Net Receivables603.1 M574.4 M328 M
Slightly volatile
Common Stock Shares Outstanding74.9 M72.7 M73.7 M
Slightly volatile
Liabilities And Stockholders Equity4.5 B4.3 B2.4 B
Slightly volatile
Non Current Liabilities Total315.6 M439.1 M383.9 M
Very volatile
Inventory466.1 M443.9 M269.3 M
Slightly volatile
Other Current Assets177 M168.6 M78.1 M
Slightly volatile
Total Liabilities1.1 B1.1 B761 M
Slightly volatile
Total Current Assets2.1 B2 B1.1 B
Slightly volatile
Short Term Debt21.7 M22.7 M35.4 M
Pretty Stable
Intangible Assets7.3 M7.7 M26.3 M
Slightly volatile
Accounts Payable266.4 M253.7 M161.7 M
Slightly volatile
Property Plant And Equipment Gross3.5 B3.3 B1.5 B
Slightly volatile
Common Stock Total Equity13 M21.6 M16.4 M
Slightly volatile
Common Stock13.9 M21.6 M16.4 M
Slightly volatile
Other Liabilities107.9 M130.2 M119.8 M
Pretty Stable
Long Term Debt199.9 M202.8 M235.5 M
Slightly volatile
Good Will104.3 M109.9 M105 M
Slightly volatile
Property Plant Equipment1.9 B1.8 B1 B
Slightly volatile
Current Deferred Revenue35.5 M44.6 M36.7 M
Pretty Stable
Net Tangible Assets3.1 B2.9 B1.6 B
Slightly volatile
Long Term Debt Total192 M202.8 M244.7 M
Slightly volatile
Long Term Investments146.3 M212.3 M129.5 M
Slightly volatile
Non Current Liabilities Other95.6 M75.2 M121.1 M
Slightly volatile
Deferred Long Term Asset Charges12 M12.6 M39.6 M
Slightly volatile
Short and Long Term Debt161.8 M154.1 M49.9 M
Slightly volatile
Cash And Equivalents617.9 M791.3 M438.4 M
Slightly volatile
Net Invested Capital2.7 B3.4 B2.1 B
Slightly volatile
Net Working Capital1.1 B1.3 B771.1 M
Slightly volatile
Capital Stock15 M16.9 M18.5 M
Slightly volatile
Capital Lease Obligations101.2 M118.3 M82 M
Slightly volatile

West Pharmaceutical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization66.2 M124.4 M97.7 M
Slightly volatile
Total Revenue3.2 B3.1 B2 B
Slightly volatile
Gross Profit1.2 B1.1 B692.5 M
Slightly volatile
Other Operating Expenses2.6 B2.5 B1.6 B
Slightly volatile
Operating Income648.3 M617.4 M367 M
Slightly volatile
EBIT629.2 M599.2 M357.6 M
Slightly volatile
EBITDA759.8 M723.6 M459.1 M
Slightly volatile
Cost Of Revenue2.1 B2 B1.3 B
Slightly volatile
Total Operating Expenses510.2 M485.9 M320.3 M
Slightly volatile
Income Before Tax646.1 M615.3 M358.6 M
Slightly volatile
Net Income518.4 M493.7 M290.7 M
Slightly volatile
Income Tax Expense127.7 M121.6 M70 M
Slightly volatile
Selling General Administrative207.5 M388.7 M264.1 M
Slightly volatile
Research Development78 M74.3 M46.7 M
Slightly volatile
Net Income Applicable To Common Shares518.4 M493.7 M286.9 M
Slightly volatile
Net Income From Continuing Ops299.8 M493.7 M274.1 M
Slightly volatile
Tax Provision90.8 M121.6 M66.5 M
Slightly volatile
Interest Income10.2 M17 M10.3 M
Pretty Stable
Reconciled Depreciation137 M171.4 M113.8 M
Slightly volatile

West Pharmaceutical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.9 M23.8 M20.2 M
Slightly volatile
Free Cash Flow492.3 M468.9 M214.2 M
Slightly volatile
Begin Period Cash Flow508.8 M484.6 M380.2 M
Slightly volatile
Depreciation177 M168.6 M107.3 M
Slightly volatile
Capital Expenditures300.2 M285.9 M190.1 M
Slightly volatile
Total Cash From Operating Activities792.5 M754.8 M404.3 M
Slightly volatile
Net Income518.4 M493.7 M291 M
Slightly volatile
End Period Cash Flow830.9 M791.3 M439 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.86.47195.2558
Slightly volatile
Dividend Yield0.00290.00310.0064
Slightly volatile
PTB Ratio6.586.26346.1926
Slightly volatile
Days Sales Outstanding43.3768.209655.9497
Slightly volatile
Book Value Per Share46.1243.928122.8655
Slightly volatile
Free Cash Flow Yield0.02480.02360.0199
Slightly volatile
Operating Cash Flow Per Share10.9610.43985.5444
Slightly volatile
Stock Based Compensation To Revenue0.00860.00770.0111
Pretty Stable
Capex To Depreciation1.261.69571.6898
Slightly volatile
PB Ratio6.586.26346.1926
Slightly volatile
EV To Sales6.676.355.2304
Slightly volatile
Free Cash Flow Per Share6.816.48552.9266
Slightly volatile
ROIC0.07480.13620.1206
Slightly volatile
Inventory Turnover6.344.43885.0607
Slightly volatile
Net Income Per Share7.176.82853.9725
Slightly volatile
Days Of Inventory On Hand52.4182.228772.7605
Slightly volatile
Payables Turnover11.77.76678.6064
Slightly volatile
Research And Ddevelopement To Revenue0.01690.02420.0225
Pretty Stable
Capex To Revenue0.110.0930.096
Pretty Stable
Cash Per Share11.4910.94476.0301
Slightly volatile
POCF Ratio27.6726.354826.3185
Slightly volatile
Interest Coverage19418564.1387
Slightly volatile
Payout Ratio0.120.1240.2004
Slightly volatile
Capex To Operating Cash Flow0.360.37880.5377
Slightly volatile
PFCF Ratio44.5542.42458.0039
Pretty Stable
Days Payables Outstanding29.0146.995843.4062
Slightly volatile
Income Quality1.451.52891.5903
Slightly volatile
ROE0.0960.15540.1517
Slightly volatile
EV To Operating Cash Flow13.8825.858525.5879
Slightly volatile
PE Ratio23.7840.292937.1519
Slightly volatile
Return On Tangible Assets0.06050.11890.108
Slightly volatile
EV To Free Cash Flow43.7141.625158.8339
Pretty Stable
Earnings Yield0.04520.02480.0318
Slightly volatile
Intangibles To Total Assets0.02620.02750.0621
Slightly volatile
Current Ratio1.863.02062.737
Pretty Stable
Tangible Book Value Per Share44.4242.301521.0841
Slightly volatile
Receivables Turnover7.585.35116.6514
Slightly volatile
Graham Number86.2682.153345.1068
Slightly volatile
Shareholders Equity Per Share46.1243.928123.1721
Slightly volatile
Debt To Equity0.120.13120.2365
Slightly volatile
Capex Per Share4.153.95442.6179
Slightly volatile
Revenue Per Share44.6442.513127.1315
Slightly volatile
Interest Debt Per Share6.065.77184.36
Pretty Stable
Debt To Assets0.09270.09760.1437
Slightly volatile
Enterprise Value Over EBITDA28.3226.973522.4802
Slightly volatile
Short Term Coverage Ratios54.8433.251180.7211
Pretty Stable
Price Earnings Ratio23.7840.292937.1519
Slightly volatile
Operating Cycle95.78150129
Slightly volatile
Price Book Value Ratio6.586.26346.1926
Slightly volatile
Days Of Payables Outstanding29.0146.995843.4062
Slightly volatile
Dividend Payout Ratio0.120.1240.2004
Slightly volatile
Price To Operating Cash Flows Ratio27.6726.354826.3185
Slightly volatile
Price To Free Cash Flows Ratio44.5542.42458.0039
Pretty Stable
Pretax Profit Margin0.210.20020.1636
Slightly volatile
Ebt Per Ebit0.710.99660.9549
Very volatile
Operating Profit Margin0.10.20090.1607
Slightly volatile
Effective Tax Rate0.290.19760.2345
Slightly volatile
Company Equity Multiplier2.091.34451.5906
Slightly volatile
Long Term Debt To Capitalization0.08160.08590.156
Slightly volatile
Total Debt To Capitalization0.110.1160.1818
Slightly volatile
Return On Capital Employed0.10.17080.1594
Slightly volatile
Debt Equity Ratio0.120.13120.2365
Slightly volatile
Ebit Per Revenue0.10.20090.1607
Slightly volatile
Quick Ratio1.32.34282.0004
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.282.17461.64
Slightly volatile
Net Income Per E B T0.580.80240.7579
Slightly volatile
Cash Ratio1.271.20831.0231
Slightly volatile
Cash Conversion Cycle95.710388.6988
Slightly volatile
Operating Cash Flow Sales Ratio0.260.24560.1875
Slightly volatile
Days Of Inventory Outstanding52.4182.228772.7605
Slightly volatile
Days Of Sales Outstanding43.3768.209655.9497
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.650.62120.4629
Slightly volatile
Cash Flow Coverage Ratios1.91.81141.3051
Slightly volatile
Price To Book Ratio6.586.26346.1926
Slightly volatile
Fixed Asset Turnover1.581.541.9625
Pretty Stable
Capital Expenditure Coverage Ratio2.772.64012.0289
Slightly volatile
Price Cash Flow Ratio27.6726.354826.3185
Slightly volatile
Enterprise Value Multiple28.3226.973522.4802
Slightly volatile
Debt Ratio0.09270.09760.1437
Slightly volatile
Cash Flow To Debt Ratio1.91.81141.3051
Slightly volatile
Price Sales Ratio6.86.47195.2558
Slightly volatile
Return On Assets0.120.11560.1058
Slightly volatile
Asset Turnover0.970.71980.8528
Slightly volatile
Net Profit Margin0.170.16060.1286
Slightly volatile
Gross Profit Margin0.260.35890.3346
Slightly volatile
Price Fair Value6.586.26346.1926
Slightly volatile
Return On Equity0.0960.15540.1517
Slightly volatile

West Pharmaceutical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap236.5 M442.1 M456.5 M
Very volatile
Enterprise Value252.4 M374.8 M393.1 M
Very volatile

West Fundamental Market Drivers

Forward Price Earnings33.4448
Cash And Short Term Investments791.3 M

West Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About West Pharmaceutical Financial Statements

West Pharmaceutical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses on on West Pharmaceutical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue44.6 M35.5 M
Total Revenue3.1 B3.2 B
Cost Of Revenue2 B2.1 B
Stock Based Compensation To Revenue 0.01  0.01 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue 0.09  0.11 
Revenue Per Share 42.51  44.64 
Ebit Per Revenue 0.20  0.10 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY